Statistics in Medicine

Article	Citations
	167
Skewness‐Corrected Confidence Intervals for Predictive Values in Enrichment Studies	94
	78
The Whys, Whens, and Hows of Futility Monitoring	71
Issue Information	56
	50
Confidence Intervals for AUC and pAUC by Empirical Likelihood	41
A Proposal for Homoskedastic Modeling With Conditional Auto‐Regressive Distributions	39
Cumulative Logit Ordinal Regression With Proportional Odds Under Nonignorable Missing Responses—Application to Phase III Trial	37
Optimal confidence intervals for the relative risk and odds ratio	36
Synthesizing studies for comparing different treatment sequences in clinical trials	33
Network and covariate adjusted response‐adaptive design for binary response	32
Leveraging External Aggregated Information for the Marginal Accelerated Failure Time Model	31
	30
Dose finding studies for therapies with late‐onset toxicities: A comparison study of designs	29
Correction to “A Comparison of Methods to Adjust Survival Curves for Confounders”	29
Handling Missing Outcome Data in Cluster Randomized Trials With Both Individual‐ and Cluster‐Level Dropout	28
BEATS: Bayesian hybrid design with flexible sample size adaptation for time‐to‐event endpoints	28
A Review of Methods for Research Synthesis	28
Semiparametric Partial Functional Regression Model for Estimating Optimal Individualized Treatment Regime	28
Accounting for Misclassification of Binary Outcomes in External Control Arm Studies for Unanchored Indirect Comparisons: Simulations and Applied Example	25
Bayesian additive regression trees for multivariate skewed responses	24
Semiparametric multivariate joint model for skewed‐longitudinal and survival data: A Bayesian approach	24
Data fusion for predicting long‐term program impacts	23
Probabilistic Clustering Using Multivariate Growth Mixture Model in Clinical Settings—A Scleroderma Example	23

Bayesian mixture modelling with ranked set samples	23
Issue Information	22
Flexible Empirical Bayesian Approaches to Pharmacovigilance for Simultaneous Signal Detection and Signal Strength Estimation in Spontaneous Reporting Systems Data	22
Multi‐Study Factor Regression Model: An Application in Nutritional Epidemiology	22
Modeling the multi‐state natural history of rare diseases with heterogeneous individual patient data: A simulation study	22
Dynamic Single‐Index Scalar‐On‐Function Model	22
Structured Nonlinear Cure Model With Deep Neural Networks for High‐Dimensional Survival Analysis	22
	21
Balancing versus modelling in weighted analysis of non‐randomised studies with survival outcomes: A simulation study	21
Bayesian Safety and Futility Monitoring in Phase II Trials Using One Utility‐Based Rule	21
Evaluating joint confidence region of hypervolume under ROC manifold and generalized Youden index	21
Transportability of model‐based estimands in evidence synthesis	20
Bayesian Borrowing With Multiple Heterogeneous Historical Studies Using Order Restricted Normalized Power Prior	20
Sample size considerations for assessing treatment effect heterogeneity in randomized trials with heterogeneous intracluster correlations and variances	20
Predictor‐Assisted Nonparametric Graphical Models With Multivariate Error‐Prone Data	20
On the parameter estimation of Box‐Cox transformation cure model	20
A Hierarchical Bayesian Model for Estimating Age‐Specific COVID‐19 Infection Fatality Rates in Developing Countries	19
Relative sparsity for medical decision problems	19
Regression Trees With Fused Leaves	19
Adjusted Nelson–Aalen Estimators by Inverse Treatment Probability Weighting With an Estimated Propensity Score	18
An inverse probability weighted regression method that accounts for right‐censoring for causal inference with multiple treatments and a binary outcome	18
Overview and Practical Recommendations on Using Shapley Values for Identifying Predictive Biomarkers via CATE Modeling	18
Issue Information	18
A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart	18
Adaptive Incorporation of External Summary Information in the Cox Regression Under Population Heterogeneity	17
A Functional Approach to Testing Overall Effect of Interaction Between DNA Methylation and SNPs	17
Issue Information	16
Estimating contact network properties by integrating multiple data sources associated with infectious diseases	16
Sensitivity analysis of G‐estimators to invalid instrumental variables	16
Information‐incorporated sparse hierarchical cancer heterogeneity analysis	15
Multilevel Longitudinal Functional Principal Component Model	15
Finding the best subgroup with differential treatment effect with multiple outcomes	15
	15
Instrumental variable analysis for cost outcome: Application to the effect of primary care visit on medical cost among low‐income adults	15
Modeling variation in mixture effects over space with a Bayesian spatially varying mixture model	15
Random Survival Forest With Multiple Imputation Analysis for Case‐Cohort and Generalized Case‐Cohort Studies	15
A Bayesian method to detect drug‐drug interaction using external information for spontaneous reporting system	15
Nonparametric empirical Bayes biomarker imputation and estimation	15
Robust Estimation of Additive Shared‐Frailty Models for Recurrent Event Data With Dependent Censoring	15
Multiple multi‐sample testing under arbitrary covariance dependency	15
Joint Frailty Mixture Cure Model for Recurrent Event Data With Dependent Censoring: An MCEM Approach	14
Distribution–free hyperrectangular tolerance regions for setting multivariate reference regions in laboratory medicine	14
Multilevel joint model of longitudinal continuous and binary outcomes for hierarchically structured data	14
BAR12 : Bayesian Autoregressive Phase 1‐2 Design for Cell Therapy Trials With Manufacturing Changes	14
Natural Effects in the Presence of an Intermediate Confounder: Evaluation of Pragmatic Estimation Strategies With an Emphasis on the Relationship Between Natural and Interventional Effects	14
Modeling intra‐individual inter‐trial EEG response variability in autism	14
A combined multilevel factor analysis and covariance regression model with mixed effects in the mean and variance structure	14
A Novel Stratified Analysis Method for Testing and Estimating Overall Treatment Effects on Time‐To‐Event Outcomes Using Average Hazard With Survival Weight	13
What's the Weight? Estimating Controlled Outcome Differences in Complex Surveys for Health Disparities Research	13
Covariate adjustment in randomized clinical trials with missing covariate and outcome data	13

Adjusted closed‐form confidence interval formulas for network meta‐analysis with a small number of studies	13
Instrumental variable model average with applications in Mendelian randomization	13
An Empirical Assessment of the Cost of Dichotomization of the Outcome of Clinical Trials	13
Outlier Detection in Mendelian Randomization	13
A Biomarker Signature‐Guided Clinical Trial Design for Precision Medicine	13
Asymptotic Confidence Interval, Sample Size Formulas and Comparison Test for the Agreement Intra‐Class Correlation Coefficient in Inter‐Rater Reliability Studies	12
Issue Information	12
Quantile partially linear additive model for data with dropouts and an application to modeling cognitive decline	12
	12
A systematic review and evaluation of statistical methods for group variable selection	12
	12
Issue Information	12
Kernel Cox partially linear regression: Building predictive models for cancer patients' survival	12
Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta‐Diversity	12
	12
	12
Standardization and other approaches to meta‐analyze differences in means	12
Group sequential designs for clinical trials when the maximum sample size is uncertain	12
Non‐Parametric Estimation for Semi‐Competing Risks Data With Event Misascertainment	12
Transfer Learning for Error‐Contaminated Poisson Regression Models	11
Estimating mixture effects and cumulative spatial risk over time simultaneously using a Bayesian index low‐rank kriging multiple membership model	11
Penalized smoothing splines resolve the curvature identifiability problem in age‐period‐cohort models with unequal intervals	11
Propensity score analysis with local balance	11
Genetic Prediction Modeling in Large Cohort Studies via Boosting Targeted Loss Functions	11
The impact of correlated exposures and missing data on multiple informant models used to identify critical exposure windows	11
Causal Inference in the Presence of Missing Outcome and Treatment Variables: Triply Robust Estimator and Sensitivity Analysis	11
Joint regression modelling of intensity and timing of accelerometer counts	11
A Bayesian Two‐Step Multiple Imputation Approach Based on Mixed Models for Missing EMA Data	11
Q‐Learning in Dynamic Treatment Regimes With Misclassified Binary Outcome	11
Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial	10
Handling missing within‐study correlations in the evaluation of surrogate endpoints	10
Association analysis of self‐reported outcomes with a validated subset	10
Robust inference for causal mediation analysis of recurrent event data	10
Correction to “Using principal stratification in analysis of clinical trials”	10
Confidence Interval Construction for Causally Generalized Estimates With Target Sample Summary Information	10
Improve the Precision of Area Under the Curve Estimation for Recurrent Events Through Covariate Adjustment	10
BHAFT: Bayesian heredity‐constrained accelerated failure time models for detecting gene‐environment interactions in survival analysis	10
Obituary: Anthony Leonard Johnson (1943‐2022)	10
An information‐theoretic approach for the assessment of a continuous outcome as a surrogate for a binary true endpoint based on causal inference: Application to vaccine evaluation	10
Local false discovery rate estimation with competition‐based procedures for variable selection	10
A non‐parametric Bayesian approach for adjusting partial compliance in sequential decision making	10
Variability in Causal Effects and Noncompliance in a Multisite Trial: A Bivariate Hierarchical Generalized Random Coefficients Model for a Binary Outcome	10
Structured time‐dependent inverse regression (STIR)	10
Subgroup Testing in the Change‐Plane Cox Model	10
Frequentist Grouped Weighted Quantile Sum Regression for Correlated Chemical Mixtures	10
Illustrating Implications of Misaligned Causal Questions and Statistics in Settings With Competing Events and Interest in Treatment Mechanisms	10
Flexible template matching for observational study design	10
Designing individually randomized group treatment trials with repeated outcome measurements using generalized estimating equations	10
Score Matching for Differential Abundance Testing of Compositional High‐Throughput Sequencing Data	9
A Tutorial on Bayesian Multi‐Study Factor Analysis With Applications in Nutrition and Genomics	9
Flexible propensity score estimation strategies for clustered data in observational studies	9
	9
A Practical Framework to Design Immunization Studies Based on the Beta Distribution	9
Ensemble of Sequential Learning Models With Distributed Data Centers and Its Applications	9
Structure Identification, Estimation and Variable Selection for Varying Coefficient EV Models With Longitudinal Data	9
On “Confirmatory” Methodological Research in Statistics and Related Fields	9
Inverse probability of treatment weighting with generalized linear outcome models for doubly robust estimation	9
	9
	9
Optimal weighted Bonferroni tests and their graphical extensions	9
Two‐Step Error‐Controlling Classifiers With Application to Cost‐Effective Disease Diagnosis	9
Extending the Median Odds Ratio ( MOR ), the Interval Odds Ratio ( IOR ), and the Proportion of Op	9
Bland–Altman Plot for Censored Variables	9
A Brief Introduction on Latent Variable Based Ordinal Regression Models With an Application to Survey Data	9
	9
Statistical inference for time‐to‐event data in non‐randomized cohorts with selective attrition	9
Blinded sample size re‐estimation for comparing over‐dispersed count data incorporating follow‐up lengths	8
Integrating Multiple Clustering Techniques and Performance Measures via Ranking for scRNA‐Seq Data	8
MERIT: Controlling Monte‐Carlo error rate in large‐scale Monte‐Carlo hypothesis testing	8
Issue Information	8
Statistical Inference for a Two‐Stage Adaptive Seamless Design Using Different Binary Endpoints	8
Multi‐threshold proportional hazards model and subgroup identification	8
A Simple Diagnostic for the Positivity Assumption for Continuous Exposures	8
The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints	8
A function‐based approach to model the measurement error in wearable devices	8
Probability of Success for Establishing Noninferiority Across Multiple Visits: Extension of Covariate‐Adjusted Bayesian Hierarchical Modeling Framework	8
Extended Joinpoint Regression Methodology for Complex Survey Data	8
Issue Information	8
On GEE for Mean‐Variance‐Correlation Models: Variance Estimation and Model Selection	8
Confidence intervals for odds ratio from multistage randomized phase II trials	8

Issue Information	8
Accommodating Spatial Heterogeneity in Geographically Weighted Regression with Group Penalty	8
Deep Mixture of Linear Mixed Models for Complex Longitudinal Data	8
Causal Inference for First Non‐Fatal Events With the Competing Risk of Death: A Principal Stratification Approach	8
Scaled average bioequivalence methods for highly variable drugs: Leveling‐off soft limits and the EMA's 2010 guideline (some ways to improve its type I error control)	8
Issue Information	8
A Unified Framework for Modeling Feedback and Endogeneity in Longitudinal Binary Outcomes Using Bayesian Methods	8
A Varying‐Coefficient Additive Hazard Model for Recurrent Events Data	8
Sample size determination for prediction models via learning‐type curves	8
Comparison of Methods for Sensitivity Analysis of Heterogeneous Treatment Effects in Observational Studies and Application to Alzheimer's Disease and Cognitive Decline	7
Federated causal inference in heterogeneous observational data	7
Fitting a stochastic model of intensive care occupancy to noisy hospitalization time series during the COVID‐19 pandemic	7
Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs	7
Bayesian predictive model averaging approach to joint longitudinal‐survival modeling: Application to an immuno‐oncology clinical trial	7
A proper statistical inference framework to compare clinical trial and real‐world progression‐free survival data	7
Frequentist Identification of Effective Baskets via the Generalized Information Criteria in Oncology Phase 2 Trials	7
Robust analysis of cancer heterogeneity for high‐dimensional data	7
Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance	7
A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards	7
Power and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness‐Implementation Studies	7
An Augmented Likelihood Approach Incorporating Error‐Prone Auxiliary Data Into a Survival Analysis	7
Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation	7
Multilevel Regression and Poststratification Using Margins of Poststratifiers: Improving Inference for HIV Health Outcomes During the COVID‐19 Pandemic	7
Survival Analysis Under the Aalen's Additive Hazards Model With Covariate Measurement Error: Application to Causal Mediation Analysis	7
Properties of the full random‐effect modeling approach with missing covariate data	7
Joint Bayesian Nowcasting of Severe Acute Respiratory Illness and COVID‐19 Positives in Brazil	7
Low‐rank latent matrix‐factor prediction modeling for generalized high‐dimensional matrix‐variate regression	7
Unlocking Cognitive Analysis Potential in Alzheimer's Disease Clinical Trials: Investigating Hierarchical Linear Models for Analyzing Novel Measurement Burst Design Data	7
	7
A Bayesian Multivariate Model With Temporal Dependence on Random Partition of Areal Data for Mosquito‐Borne Diseases	7
Low‐Rank Variational Correction Estimation for Multi‐Source Heterogeneous Quantile Linear Regression Models	7
Testing for the Functional Form of a Continuous Covariate in the Shared‐Parameter Joint Model	7
Covariate‐Adjusted Group Sequential Comparisons of Survival Probabilities	7
An Alternative Measure for Quantifying the Heterogeneity in Meta‐Analysis	7
	7
Subgroup analysis using Bernoulli‐gated hierarchical mixtures of experts models	7
Allocation in platform trials to maintain comparability across time and eligibility	7
Moving Toward Best Practice When Using Propensity Score Weighting in Survey Observational Studies	7
Multivariate functional mixed model with MRI data: An application to Alzheimer's disease	7
Bayesian Modeling of Cancer Outcomes Using Genetic Variables Assisted by Pathological Imaging Data	7
Minimization in randomized clinical trials	7
Saddlepoint approximations to score test statistics in logistic regression for analyzing genome‐wide association studies	7
A nonparametric simultaneous confidence band for biomarker effect on the restricted mean survival time	7
A sequential, multiple assignment, randomized trial design with a tailoring function	7
Clustering‐Informed Shared‐Structure Variational Autoencoder for Missing Data Imputation in Large‐Scale Healthcare Data	7
The Cox Model With Adaptive Fused Group Bridge Penalty to Incorporate Historical Data Into the Analysis of Clinical Trials With an Application to BMT CTN 1101	6
Partially Linear Additive Quantile Regression: Theory and Applications to Breast Cancer Patients' Survival	6
Performance of Cross‐Validated Targeted Maximum Likelihood Estimation	6
Fusing trial data for treatment comparisons: Single vs multi‐span bridging	6
Matching‐Assisted Power Prior for Incorporating Real‐World Data in Randomized Clinical Trial Analysis	6
Two‐stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers	6
LEARNER: A Transfer Learning Method for Low‐Rank Matrix Estimation	6
A Commentary on Chatterjee Et Al. (2018): A Corrected Framework for Group Sparsity in Zero‐Inflated Negative Binomial Models	6
Assessing heterogeneity in surrogacy using censored data	6
A Bayesian semi‐parametric scalar‐on‐function regression with measurement error using instrumental variables	6
Bayesian Variable Selection for High‐Dimensional Mediation Analysis: Application to Metabolomics Data in Epidemiological Studies	6
A Comparison of Testing Procedures for Detecting Short‐ and Long‐Term Effects of Biomarkers for Cancer Screening	6
Likelihood Confidence Intervals for Misspecified Cox Models	6
Analysis of Cohort Stepped Wedge Cluster‐Randomized Trials With Nonignorable Dropout via Joint Modeling	6
Multivariate and Online Transfer Learning With Uncertainty Quantification	6
Refined moderation analysis with categorical outcomes in precision medicine	6
Score Test for Functional Markov Process With Image Predictor	6
Integrative deep learning with prior assisted feature selection	6
A Note on the Sample Size Formula for a Win Ratio Endpoint	6
Multiblock partial least squares and rank aggregation: Applications to detection of bacteriophages associated with antimicrobial resistance in the presence of potential confounding factors	6
Distributional imputation for the analysis of censored recurrent events	6
Radiomics of PET Using Neural Networks for Prediction of Alzheimer's Disease Diagnosis	6
Joint modeling approaches for censored predictors due to detection limits with applications to metabolites data	6
Fast estimation of mixed‐effects location‐scale regression models	6
Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo	6
Penalized maximum likelihood inference under the mixture cure model in sparse data	6
Confidence Set for the Cluster of a Spatial Scan Statistic	6
Reinforced Borrowing Framework: Leveraging Auxiliary Data for Individualized Inference	6
Approximate maximum likelihood estimation in cure models using aggregated data, with application to HPV vaccine completion	6
Optimal ensemble construction for multistudy prediction with applications to mortality estimation	6
A comparison of different methods to adjust survival curves for confounders	6
Unified semicompeting risks analysis of hepatitis natural history through mediation modeling	6
A Bayesian Optimal Adaptive Clinical Trial Design for Sequentially Integrated Therapies	6
Covariate Balancing With Measurement Error	6
Tony Johnson—memories and a tribute	6
Parameter estimation and forecasting with quantified uncertainty for ordinary differential equation models using QuantDiffForecast: A MATLAB toolbox and tutorial	6
Gaussian variational approximate inference for joint models of longitudinal biomarkers and a survival outcome	6
A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability‐nonexchangeability method	6
A Bayesian non‐stationary heteroskedastic time series model for multivariate critical care data	6
Bayesian Power Prior in Platform Trials With Non‐Concurrent Control for Binary Outcomes: Development and Comparative Evaluation	6
Fitting additive risk models using auxiliary information	6
Exploiting relationship directionality to enhance statistical modeling of peer‐influence across social networks	6
	6
Sensitivity Analysis for Effects of Multiple Exposures in the Presence of Unmeasured Confounding: Non‐Gaussian and Time‐to‐Event Outcomes	6
The Design of Large‐Scale Plasma Donation Trials	6
A comparison of hyperparameter tuning procedures for clinical prediction models: A simulation study	5
Point estimation for adaptive trial designs II: Practical considerations and guidance	5
Categorisation of continuous covariates for stratified randomisation: How should we adjust?	5
Confidence Intervals and Sample Size for the ICC in Two‐Way ANOVA Models	5
Cluster randomized trial designs for modeling time‐varying intervention effects	5